Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene

Molecular Endocrinology

Volumn 13, Issue 10, 1999, Pages 1629-1644

  Malkoski, Stephen P ^a   Dorin, Richard I ^a  

^a VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CYCLIC AMP RESPONSIVE ELEMENT; DNA RESPONSIVE ELEMENT; GENE ACTIVITY; GENE REPRESSION; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

EID: 0033305069     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.10.0351     Document Type: Article

References (68)

1. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat
2. CRF mRNA in normal and stress conditions
3. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
4. Molecular and transgenic studies of the corticotropin-releasing hormone gene
5. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome
6. Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus
7. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy
8. Morphometrical analysis of the distribution of corticotrophin releasing factor, glucocorticoid receptor and phenylethanolamine-N-methyltransferase immunoreactive structures in the paraventricular hypothalamic nucleus of the rat
9. Ontogeny of the glucocorticoid receptor in the rat brain
10. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: A detailed protocol
11. Rapid regulation of corticotropin-releasing hormone gene transcription in vivo
12. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress
13. Differential regulation of corticotropin-releasing hormone mRNA in rat brain
14. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta
15. Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene
16. Negative giucocorticoid regulation of cyclic adenosine 3',5'-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells
17. Glucocorticoid repression of 3',5'-cyclic-adenosine monophosphate-dependent human corticotropin-releasing-hormone gene promoter activity in a transfected mouse anterior pituitary cell line
18. Expression and dexamethasone regulation of the human corticotropin-releasing hormone gene in a mouse anterior pituitary cell line
19. Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter
20. Immortalization of a fetal rat brain cell line that expresses corticotropin-releasing factor mRNA
21. The cAMP-responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization
22. Structural organization of the 5' flanking region of the human corticotropin releasing hormone gene
23. DNA-binding by the glucocorticoid receptor: A structural and functional analysis
24. Structural determinants of DNA-binding specificity by steroid receptors
25. Protein-protein interactions are implied in glucocorticoid receptor mutant 465*-mediated cell death
26. Distinct domains of the ReIA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor
27. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors
28. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: A potential mechanism for negative regulation
29. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: Enhancer, TATA box, and RNA start site (Inr motif) occlusion
30. Role of the composite glucocorticoid response element in proliferin gene expression
31. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element
32. Regulation of α-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site
33. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of ReIA transactivation
34. Negative cross-talk between ReIA and the glucocorticoid receptor: A possible mechanism for the anti-inflammatory action of glucocorticoids
35. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action
36. Transcription. A growing coactivator network
37. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
38. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene
39. Hormone-mediated repression: A negative glucocorticoid response element from the bovine prolactin gene
40. Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells
41. Interference between pathway-specific transcription factors: Glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo
42. Solution structure of the glucocorticoid receptor DNA-binding domain
43. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids
44. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer
45. Cyclic AMP and phorbol ester-stimulated transcription mediated by similar DNA elements that bind distinct proteins
46. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements
47. Structure/function relationships of CREB/ATF proteins
48. Too many transcription factors: Positive and negative interactions
49. Transcriptional regulation of human corticotropin releasing factor gene expression by cyclic adenosine 3',5'-monophosphate: Differential effects at proximal and distal promoter elements
50. Second messenger regulation of mRNA for corticotropin-releasing factor
51. Eukaryotic regulatory elements linking in plasmid DNA: The activator protein-1 site in pUC
52. Efficient binding of glucocorticoid receptor to its responsive element requires a dimer and DNA flanking sequences
53. Transcriptional interference between c-Jun and the giucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction
54. Hormonal regulation of human corticotropin-releasing hormone gene expression: Implications for the stress response and immune/inflammatory reaction
55. Transcriptional cross-talk: Nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun
56. Distinct adenosine 3',5'-monophosphate and phorbol ester-responsive signal transduction pathways converge at the level of transcriptional activation by the interactions of DNA-binding proteins
57. Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation
58. Heterodimer formation between CREB and JUN proteins
59. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase
60. RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38α mitogen-activated protein kinase (p38αMAPK)
61. D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells
62. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB
63. Studies on the mechanism of glucocorticoid-mediated repression from a negative glucocorticoid response element from the bovine prolactin gene
64. Gel mobility shift assay to study nuclear hormone receptor-DNA interactions
65. A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription
66. Luciferase reporter gene vectors for analysis of promoters and enhancers
67. Identification of a gonadotropin-releasing hormone-responsive region in the glycoprotein hormone a-subunit promoter
68. Functional domains of the human glucocorticoid receptor